| |
 |
Acridine and Acridone Derivatives, Anticancer Properties and Synthetic Methods: Where Are We Now?
|
| |
|
pp.139-169 (31) Authors: Philippe Belmont, Johann Bosson, Thomas Godet, Martin Tiano |
| |
|
|
| |
|
In Silico Design of Protein Kinase Inhibitors: Successes and Failures
|
| |
|
pp.171-188 (18) Authors: Galina G. Dubinina, Oleksandr O. Chupryna, Maxim O. Platonov, Petro O. Borisko, Galina V. Ostrovska, Andriy O. Tolmachov, Alexander A. Shtil |
| |
|
|
| |
|
Recent Progress in Discovery and Development of Antimitotic Agents
|
| |
|
pp.189-208 (20) Authors: Alex Kiselyov, Konstantin V. Balakin, Sergey E. Tkachenko, Nikolay Savchuk, Alexandre V. Ivachtchenko |
| |
|
|
| |
|
Meta-Analysis of Anticancer Drug Structures - Significance of Their Polar Allylic Moieties
|
| |
|
pp.209-222 (14) Author: Norman S. Radin |
| |
|
|
| |
|
Vascular Endothelial Growth Factor (VEGF) Inhibition - A Critical Review
|
| |
|
pp.223-245 (23) Authors: Irina Sousa Moreira, Pedro Alexandrino Fernandes, Maria Joao Ramos |
| |
|
|
| |
|
Antitumor Carbazoles
|
| |
|
pp.247-267 (21) Authors: Christian Asche, Martine Demeunynck |
| |
|
|
